Abstract
Inhibitors targeting the influenza A virus M2 (A/M2) proton channel have lost their effectiveness due to widespread resistance. As a first step in the development of new inhibitors that address this problem, we have screened several focused collections of small molecules using two-electrode voltage patch clamp assays (TEVC) on Xenopus laevis oocytes. Diverse head groups and scaffolds of A/M2 inhibitors have been explored. It has been found that not only amine but also hydroxyl, aminooxyl, guanidine, and amidine compounds are active against the A/M2 proton channel. Moreover, the channel is able to accommodate a wide range of structural variation in the apolar scaffold. This study offers information to guide the next generation of A/M2 proton channel inhibitor design.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 307-312 |
| Number of pages | 6 |
| Journal | ACS Medicinal Chemistry Letters |
| Volume | 2 |
| Issue number | 4 |
| DOIs | |
| State | Published - Apr 14 2011 |
| Externally published | Yes |
Keywords
- A/M2 channel inhibitor
- Influenza A/M2
- two-electrode voltage clamp assay (TEVC)
ASJC Scopus subject areas
- Biochemistry
- Drug Discovery
- Organic Chemistry